NCT00303199View on ClinicalTrials.gov

Study of ZIO-101 in Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Multiple Myeloma
Interventions
DRUG

ZIO-101 (Darinaparsin)

IV zio-101 (Darinaparsin) give for 5 consecutive days to be repeated every 28 days for up to 6 months

Trial Locations (8)

Unknown

Little Rock

West Hollywood

Miami

Bethesda

New York

Cleveland

Edmonton

Toronto

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY